Results 21 to 30 of about 78,274 (168)

Medicinal Cannabis for the Treatment of Chronic Refractory Pain: An Investigation of the Adverse Event Profile and Health-Related Quality of Life Impact of an Oral Formulation

Medical Cannabis and Cannabinoids, 2022
Introduction: Medicinal cannabis is prescribed in Australia for patients with chronic refractory pain conditions. However, measures of safety and effectiveness of different cannabinoids are lacking.
Sarah Abelev, Leon N. Warne, Melissa Benson, Mark Hardy, Sunny Nayee, John Barlow   +5 more
doaj   +1 more source

Cannabis and breastfeeding [PDF]

Paediatrics & Child Health, 2020
AbstractCannabis is one of the most commonly used substances in Canada with 15% of Canadians reporting use in 2019. There is emerging evidence that cannabis is linked to an impact on the developing brain in utero and adverse outcomes in infants, children, and adolescents.
openaire   +2 more sources

Cannabis sativa [PDF]

Current Biology, 2020
Schilling et al. introduce and discuss Cannabis.
Susanne, Schilling, Rainer, Melzer, Paul F, McCabe   +2 more
openaire   +2 more sources

Canadians’ use of cannabis for therapeutic purposes since legalization of recreational cannabis: a cross-sectional analysis by medical authorization status

BMC Medicine
Background There has been a precipitous decline in authorizations for medical cannabis since non-medical cannabis was legalized in Canada in 2018. This study examines the demographic and health- and medical cannabis-related factors associated with ...
Lynda G. Balneaves, Ashleigh Brown, Matthew Green, Erin Prosk, Lucile Rapin, Max Monahan-Ellison, Eva McMillan, Jonathan Zaid, Michael Dworkind, Cody Z. Watling   +9 more
doaj   +1 more source

Risk assessment of metals measured in regulated Canadian dried cannabis and cannabis vaping products: case study and perspectives

Frontiers in Toxicology
In 2018, the Cannabis Act and its regulations established a strict legal framework for controlling production, distribution, sale and possession of cannabis across Canada.
Sathish Achuthan, Andrew Waye, Hanan Abramovici   +2 more
doaj   +1 more source

In-situ TD-GCMS measurements of oxidative products of monoterpenes at typical vaping temperatures: implications for inhalation exposure to vaping products

Scientific Reports, 2022
Vaping is gaining in popularity. However, there is still much that remains unknown about the potential risk and harms of vaping. Formation of oxidative products is one of such areas that are not well understood.
Jiping Zhu, Jianjun Niu, Dharani Das, Ashley Cabecinha, Hanan Abramovici   +4 more
doaj   +1 more source

The Cannabis Terpenes [PDF]

Molecules, 2020
Terpenes are the primary constituents of essential oils and are responsible for the aroma characteristics of cannabis. Together with the cannabinoids, terpenes illustrate synergic and/or entourage effect and their interactions have only been speculated in for the last few decades.
Sarana Rose Sommano, Chuda Chittasupho, Warintorn Ruksiriwanich, Pensak Jantrawut   +3 more
openaire   +3 more sources

Trends in hospitalizations for cannabinoid hyperemesis syndrome in Canada, 2016–17 to 2024–25

Frontiers in Public Health
ObjectiveTo evaluate trends in CHS hospitalizations in Canada, including their frequency and individual characteristics.MethodsThis study utilized data from the Canadian Institute for Health Information's Discharge Abstract Database to perform ...
Sieara Plebon-Huff, Samantha Goodman, Hanan Abramovici   +2 more
doaj   +1 more source

Trends in cannabis adverse reaction reports: A descriptive analysis of spontaneous reporting data submitted to the Canada Vigilance Program since legalization and regulation of cannabis for non-medical purposes in Canada

Journal of Cannabis Research
Background The cannabis control framework implemented by Canada in October 2018 established a robust post-market surveillance system for cannabis products, adopting tools and practices from the existing pharmacovigilance system for pharmaceuticals and ...
Sieara Plebon-Huff, Nadia Aziz, Marko Cavar, Safia Hassan, Maria Aoun, Shahid Perwaiz, Hanan Abramovici   +6 more
doaj   +1 more source

Higher risk cannabis use indicators among people living in Canada: a cross-sectional study examining the association with socio-demographic and socio-economic factors

Substance Abuse Treatment, Prevention, and Policy
Background In 2018, the Cannabis Act regulated the production and sale of cannabis for non-medical purposes in Canada. With the aim of continuing to protect the public health and safety of Canadians as the legal cannabis market matures, we conducted a ...
Samantha Goodman, Matthew Dann, Hanan Abramovici   +2 more
doaj   +1 more source